ESR1 and breast cancer: Estrogen receptor-negative (ER−) breast cancer (BC) comprises 15 to 30% of all breast tumours (depending on the population) and has an earlier age at onset and a worse prognosis compared with estrogen receptor-positive (ER+) disease.